Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as a sterile solution for injection for intra‑arterial, intrathecal, and intravenous use. It enhances radiographic imaging by providing radiodense contrast that improves visualization of vascular and tissue structures during diagnostic procedures.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Iomeron, an iodinated contrast agent, is used in imaging procedures that require enhanced visualization of vascular and tissue structures. - Angiography: provides high‑contrast images of blood vessels to aid diagnosis and interventional planning. - Computed Tomography (CT) imaging: improves delineation of organs and lesions for accurate assessment. - Myelography: enhances cerebrospinal fluid spaces to facilitate evaluation of spinal pathology.

Adverse reactions to Iomeron may range from mild to severe and should be monitored during and after administration.

Common Side Effects: - Warm sensation or flushing at the injection site. - Nausea or vomiting. - Transient headache. - Metallic taste in the mouth.

Serious or Rare Side Effects: - Severe allergic reaction or anaphylaxis. - Contrast‑induced nephropathy leading to acute kidney injury. - Cardiovascular collapse or severe hypotension. - Seizures or neurological disturbances. - Pulmonary edema or respiratory distress.

Prior to using Iomeron, clinicians should consider several safety measures to minimize risk. - Assess renal function: evaluate serum creatinine and eGFR before administration. - Screen for iodine or contrast media allergy: obtain detailed allergy history. - Use the lowest effective dose: tailor volume to patient size and imaging requirement. - Monitor vital signs: observe for reactions during and after injection. - Avoid in uncontrolled hyperthyroidism: iodine load may exacerbate thyroid activity. - Store at ambient temperature: keep in original container, protect from light and moisture.

Iomeron may interact with certain medications, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Thyroid hormone therapy: may increase risk of hyperthyroid crisis. - Metformin: risk of lactic acidosis in patients with renal impairment. - Loop diuretics: can potentiate renal toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may affect renal hemodynamics. - NSAIDs: increase risk of contrast‑induced nephropathy. - Calcium channel blockers: monitor blood pressure changes during injection.